Related Experiment Video
Updated: Apr 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Evaluating Long-Term Outcomes Across eGFR Equations in Older Adults.
Elisa K Bongetti1,2, Rory Wolfe3, Suzanne G Orchard3
1Department of Nephrology, Monash Medical Centre, Monash Health, Melbourne, Victoria, Australia.
Using equations validated for older adults significantly increases chronic kidney disease (CKD) prevalence but doesn't identify higher-risk individuals. Current CKD diagnostic thresholds may be inappropriate for the elderly.
Area of Science:
- Nephrology
- Geriatrics
- Epidemiology
Background:
- Current chronic kidney disease (CKD) diagnostic thresholds (eGFR < 60 ml/min/1.73 m²), based on the CKD-Epidemiology collaboration (CKD-EPI) creatinine equation, may lead to overdiagnosis in older adults.
- There is no established consensus on the optimal estimated glomerular filtration rate (eGFR) equation for older populations, leading to significant calculation variability.
Purpose of the Study:
- To investigate the impact of using eGFR equations validated for older adults (Berlin Initiative Study 1 [BIS1] and European Kidney Function Consortium [EKFC]) compared to the CKD-EPI2021 equation.
- To assess the implications of an age-adapted CKD definition (eGFR < 45 ml/min/1.73 m²) on CKD prevalence and health outcomes in older adults.
Main Methods:
- A cohort study utilizing data from the aspirin in reducing events in the elderly (ASPREE) trial and its observational follow-up (ASPREE-eXtension).
- Survival analyses compared risks of reduced disability-free survival (DFS) and major adverse cardiovascular events (MACE) between participants reclassified to different CKD stages using BIS1/EKFC versus CKD-EPI2021.
- Associations between eGFR and health outcomes were analyzed using restricted cubic splines.
Main Results:
- BIS1 and EKFC yielded eGFR values 12–15 ml/min/1.73 m² lower than CKD-EPI2021, increasing CKD prevalence from 21% to 37%–46%.
- Most participants were reclassified to a higher CKD stage, but long-term outcomes were similar between reclassified and nonreclassified groups.
- Risks of reduced DFS, all-cause mortality, or MACE were primarily observed below eGFR 45 ml/min/1.73 m², irrespective of urine albumin-to-creatinine ratio (uACR).
Conclusions:
- Employing older-age validated eGFR equations substantially increases CKD prevalence but does not identify additional high-risk individuals.
- Current CKD diagnostic thresholds may be inappropriate for older adults, especially when using equations validated for this demographic.
- Reconsidering CKD definitions within the context of aging is necessary to improve diagnostic accuracy and risk stratification.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age